1. Market Research
  2. > Healthcare
  3. > Health Facility Market Trends
  4. > Australia and New Zealand Market Study on Surgical and Respirator Masks: Australia to Witness Highest Growth by 2021

Australia and New Zealand Market Study on Surgical and Respirator Masks: Australia to Witness Highest Growth by 2021

  • August 2016
  • -
  • Persistence Market Research
  • -
  • 109 pages

Summary

Table of Contents

Surgical and respirator masks can be defined as medical devices that are used to cover mouth, nose and chin, in order to protect the healthcare professionals and patients against droplets, including large respirator particles. Surgical and respirator masks are mainly used in hospitals and day surgery centers by physicians, independent dental surgeons, veterinary surgeons and life science professionals.

The surgical and respirator mask market in Australia and New Zealand report begins with an overview. To sum it up, surgical and respirator mask products include basic surgical masks, anti-fog foam surgical masks, fluid/splash resistance surgical masks, standard fluid resistance surgical masks, face-shield fluid resistance surgical masks, standard respirator masks and particulate respirator masks.

The surgical and respirator mask market is segmented into:

1) Surgical and respirator masks, by product type
2) Surgical and respirator masks, by nature
3) Surgical and respirator masks, by end user
4) Surgical and respirator masks, by distribution channel

This report covers the surgical and respirator mask market performance in terms of the revenue contribution. This section additionally includes PMR’s analyses of the key trends, drivers, restraints and opportunities, which are influencing the surgical and respirator mask market. Impact analysis of the key growth drivers and restraints, based on the weighted average model, is included in this report on the surgical and respirator mask market in Australia and New Zealand, to better equip and arm clients with crystal clear decision-making insights.

The surgical and respirator mask market in Australia and New Zealand is mainly driven by factors such as the rise in the number of surgical procedures leading to an increased use of surgical and respirator masks, growing health and hygiene concerns, and product innovation. However, restraints faced by the surgical and respirator mask market in Australia and New Zealand are market saturation, along with unmet consumer needs, limited product availability and competition between large multinational and local players.

By product type, the surgical and respirator mask market in Australia and New Zealand is segmented into basic surgical masks, anti-fog foam surgical masks and fluid/splash resistant surgical masks. Of these, the fluid/splash resistant surgical mask market accounted for 42.2% share of the overall surgical and respirator mask market in 2014, followed by the anti-fog foam surgical masks and basic surgical masks segment. The fluid/splash resistant surgical masks segment is further sub-segmented into standard fluid resistant surgical masks and face-shield fluid resistant surgical masks. The respirator mask segment covers standard respirator masks and particulate respirator masks.The particulate respirator masks segment is further sub-segmented into cone-shaped respirator masks and flat-folded respirator masks.

By end use, the surgical and respirator mask market in Australia and New Zealand is segmented into hospitals (acute), day surgery centers, general physicians, independent dental surgeons, veterinary surgeons and life science professionals. Among all the aforementioned segments, the hospitals (acute) segment is expected to dominate the surgical and respirator mask market in Australia and New Zealand, accounting for around 45% share of the overall market by 2021, and expanding at a CAGR of 3.2% during the forecast period, i.e. 2015–2021.

Based on the distribution channel, the market is segmented into hospitals, acute care centers, clinics, drug stores and online sales. Of the above-aforementioned segments, the online sales segment is expected to expand at the highest CAGR of 5.8% during the forecast period. However, the hospitals segment is expected to dominate the surgical and respirator mask market in terms of share contribution, accounting for 43.3% share of the overall market by 2021. Also, in terms of nature, the surgical and respirator mask market is analyzed with a focus on disposable surgical masks, reusable surgical masks, disposable respirator masks and reusable respirator masks.

Key players profiled in this report on the surgical and respirator mask market in Australia and New Zealand include 3M Company, Smith & Nephew Plc., MölnlyckeHealthcare Inc., Medline Industries, Inc., Halyard Healthcare Inc. and Ansell Healthcare LLC.These key market players have been profiled on the basis of various attributes, such as company overview, recent developments, growth strategies, sustainability and financial overview.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 Analysis of the Global Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

2017 Analysis of the Global Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

  • $ 28500
  • Industry report
  • March 2017
  • by Venture Planning Group

Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during the next ten years- Examines trends in the U.S., Europe and Japan- Reviews current and emerging ...

2017-2021 World Tumor Marker Testing Market: Global Opportunities and Growth Strategies for Suppliers

2017-2021 World Tumor Marker Testing Market: Global Opportunities and Growth Strategies for Suppliers

  • $ 21100
  • Industry report
  • February 2017
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during ...

2017 Competing in the Global Cancer Diagnostics Market

2017 Competing in the Global Cancer Diagnostics Market

  • $ 21100
  • Industry report
  • March 2017
  • by Venture Planning Group

This new VPGMarketResearch.com comprehensive seven-country study identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.